Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Follow-up of the Randomized ASAP Trial Shows No Survival Advantage for Patients with Poor Responsive or Relapsed AML Who Received Intensive Salvage Chemotherapy for Remission Induction Prior to Allogeneic Transplantation Compared to Immediate Allogeneic Transplantation

Blood (2024) 144 (Supplement 1): 776.

https://doi.org/10.1182/blood-2024-204763

Published: 2024

Journal Articles

Unrelated Donors below 35 Years of Age Should be Preferred over HLA-Matched Sibling Donors Older Than 50 Years for Patients with Myeloid Malignancies

Johannes Schetelig, Henning Baldauf, Carina Rave, Gesine Bug, Lutz Peter Hermann Mueller, Eva Wagner Drouet, Francis A. Ayuk, Wolfgang Andreas Bethge, Matthias Stelljes, Thomas Schröder, Desiree Kunadt, Katja Sockel, Jan Moritz Middeke, Daniel Fürst, Alexander H. Schmidt, Katharina Fleischhauer, Martin Bornhäuser

Blood (2023) 142 (Supplement 1): 1046.

https://doi.org/10.1182/blood-2023-180531

Published: 2023

Journal Articles

MAIT Cell Frequencies within PBSC Grafts Are Associated with Donor CMV Serostatus and Age: An Initial Analysis from the DKMS and NMDP Graft Composition Study

Blood (2023) 142 (Supplement 1): 1033.

https://doi.org/10.1182/blood-2023-185153

Published: 2023

Journal Articles

Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has No Impact on Patient Outcome after Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 942.

https://doi.org/10.1182/blood-2023-179112

Published: 2023

Journal Articles

Cryopreservation Changes the Immune Effector Cell Composition of Peripheral Blood Stem Cell Grafts: An Analysis from the DKMS and NMDP Graft Composition Study

Blood (2023) 142 (Supplement 1): 1036.

https://doi.org/10.1182/blood-2023-179140

Published: 2023

Journal Articles

In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP Trial

Blood (2022) 140 (Supplement 1): 9–11.

https://doi.org/10.1182/blood-2022-159962

Published: 2022

Journal Articles

Impact of COVID-19 Pandemic on Global Unrelated Stem Cell Donations in 2020 - Report from World Marrow Donor Association

Blood (2021) 138 (Supplement 1): 3887.

https://doi.org/10.1182/blood-2021-150013

Published: 2021

Journal Articles

External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails

Blood (2020) 135 (16): 1386–1395.

https://doi.org/10.1182/blood.2019002887

Published: 2020

Includes: Supplemental data

Journal Articles

Classification of Donor KIR-Genotype Information to Predict Outcome after Unrelated Hematopoietic Stell Cell Transplantation: The Jury Is Still out

Blood (2018) 132 (Supplement 1): 2162.

https://doi.org/10.1182/blood-2018-99-111242

Published: 2018

Journal Articles

Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study

Luca Vago, MD PhD, Cristina Toffalori, Müberra Ahci, Vinzenz Lange, PhD, Kathrin Lang, Sonia Todaro, Francesca Lorentino, Karin Stempelmann, Andreas Heinold, Friedrich Stoelzel, Miguel Waterhouse, Rainer Claus, Ketevan Gendzekhadze, Masahiro Onozawa, Raynier Devillier, Ruoping Tang, Maayan Ulman, Mi Kwon, Ivana Gojo, MD, Loredana Ruggeri, Annalisa Imovilli, Luca Facchini, Dejan Lazarevic, Maria Teresa Lupo Stanghellini, Jacopo Peccatori, Nina Kristin Steckel, Peter A. Horn, Alessandra Picardi, Sara Manetta, Alessandro Busca, Jose Luis Pinana, Jaime Sanz, Carolina Martínez-Laperche, Stefan O. Ciurea, Leo Luznik, MD, Andrea Velardi, William Arcese, Guillermo Sanz, Massimo Pini, Benedetto Bruno, Guido Kobbe, Monzr Al Malki, MD, Takanori Teshima, Nicolaus Kroeger, Jürgen Finke, MD, Arnon Nagler, MD, Didier Blaise, Mohamad Mohty, MD PhD, Martin Bornhäuser, Dietrich W. Beelen, Alexander H. Schmidt, Fabio Ciceri, MD, Katharina Fleischhauer

Blood (2018) 132 (Supplement 1): 818.

https://doi.org/10.1182/blood-2018-99-112142

Published: 2018

Journal Articles

Plerixafor As a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers (NCT01954914)

Kristina Hoelig, MD, Helmuth Schmidt, MD, Gero Hütter, MD, Michael Kramer, Raphael Teipel, MD, Kristin Zimmer, MD, Matthias Blechschmidt, MD, Tigran Torosian, MD, Rainer Ordemann, MD, Frank Kroschinsky, MD, Alexander H. Schmidt, MD PhD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Johannes Schetelig, MD MSc

Blood (2016) 128 (22): 3369.

https://doi.org/10.1182/blood.V128.22.3369.3369

Published: 2016

Journal Articles

Long-Term HSC Donor Follow-up: Malignancy Incidences after Donation Are Identical Compared to a Matched Control Sample of Registered Donors, but Different to Expected General Population Rates

Thilo Mengling, MD, Camila J. Hernandez Frederick, PhD, Daniel Fandel, MS, Jürgen Sauter, PhD, Johannes Schetelig, MD M. Sc,, Alexander H. Schmidt, MD PhD, Gerhard Ehninger, MD

Blood (2015) 126 (23): 269.

https://doi.org/10.1182/blood.V126.23.269.269

Published: 2015

Journal Articles

Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR

Julia Pingel, PhD, Camila J. Hernandez Frederick, PhD, Tao Wang, PhD, Emmanuelle Polge, Michael D Haagenson, MS, Stephanie J. Lee, MD MPH, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc, Stephen R. Spellman, MBS, Alexander H. Schmidt, MD PhD, Jon J. van Rood, MD PhD

Blood (2015) 126 (23): 3226.

https://doi.org/10.1182/blood.V126.23.3226.3226

Published: 2015

Journal Articles

Prediction of Hematopoietic Stem Cell Yield after Mobilization with GCSF in Healthy Unrelated Donors

Raphael Teipel, MD, Johannes Schetelig, MD M. Sc,, Michael Kramer, PhD, Helmuth Schmidt, MD, Alexander H. Schmidt, MD PhD, Christian Thiede, MD, Kristina Hoelig, MD, Gerhard Ehninger, MD

Blood (2014) 124 (21): 1128.

https://doi.org/10.1182/blood.V124.21.1128.1128

Published: 2014

Journal Articles

7/8 High-Resolution Unrelated Donor HLA Match Rate: Caucasian, African American, Hispanic, and Asian-Pacific Islander

Kelly Buck, MT(ASCP), Jason Dehn, MPH, CHTC, Michelle Setterholm, Martin Maiers, Dennis L. Confer, MD, Robert J Hartzman, MD, Kim Wadsworth, Ph.D., Soo Young Yang, PhD, Alexander H. Schmidt

Blood (2013) 122 (21): 1998.

https://doi.org/10.1182/blood.V122.21.1998.1998

Published: 2013

Journal Articles

Duration of Unrelated Donor Search for Hematopoietic Stem Cell Transplantation

Johannes Schetelig, Christina Lehnert, Christian Klesse, Monika Füssel, Julia Pingel, Alexander H. Schmidt, Gerhard Ehninger, MD

Blood (2011) 118 (21): 2046.

https://doi.org/10.1182/blood.V118.21.2046.2046

Published: 2011

Journal Articles

Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association

Michael Boo, Suzanna M. van Walraven, Jeremy Chapman, Brian Lindberg, Alexander H. Schmidt, Bronwen E. Shaw, Galen E. Switzer, Edward Yang, Torstein Egeland, on behalf of the World Marrow Donor Association

Blood (2011) 117 (1): 21–25.

https://doi.org/10.1182/blood-2010-07-298430

Published: 2011

Journal Articles

Follow-up of 12,559 Unrelated Donors of Peripheral Blood Stem Cells or Bone Marrow

Alexander H. Schmidt, Thilo Mengling, Julia Pingel, Gabi Rall, Gerhard Ehninger

Blood (2010) 116 (21): 365.

https://doi.org/10.1182/blood.V116.21.365.365

Published: 2010

Journal Articles

Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors

Kristina Hölig, Michael Kramer, Frank Kroschinsky, Martin Bornhäuser, Thilo Mengling, Alexander H. Schmidt, Claudia Rutt, Gerhard Ehninger

Blood (2009) 114 (18): 3757–3763.

https://doi.org/10.1182/blood-2009-04-218651

Published: 2009

Journal Articles

Efficiency of HLA-A, -B, -C, -DRB1 High-Resolution Typings of Newly Recruited Potential Stem Cell Donors.

Alexander H. Schmidt, MD, PhD, Andrea Stahr, Daniel Baier, Gerhard Ehninger, MD, Claudia Rutt

Blood (2006) 108 (11): 5415.

https://doi.org/10.1182/blood.V108.11.5415.5415

Published: 2006

NARROW

Follow-up of the Randomized ASAP Trial Shows No Survival Advantage for Patients with Poor Responsive or Relapsed AML Who Received Intensive Salvage Chemotherapy for Remission Induction Prior to Allogeneic Transplantation Compared to Immediate Allogeneic Transplantation

Unrelated Donors below 35 Years of Age Should be Preferred over HLA-Matched Sibling Donors Older Than 50 Years for Patients with Myeloid Malignancies

MAIT Cell Frequencies within PBSC Grafts Are Associated with Donor CMV Serostatus and Age: An Initial Analysis from the DKMS and NMDP Graft Composition Study

Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has No Impact on Patient Outcome after Hematopoietic Stem Cell Transplantation

Cryopreservation Changes the Immune Effector Cell Composition of Peripheral Blood Stem Cell Grafts: An Analysis from the DKMS and NMDP Graft Composition Study

Impact of COVID-19 Pandemic on Global Unrelated Stem Cell Donations in 2020 - Report from World Marrow Donor Association

External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails

Classification of Donor KIR-Genotype Information to Predict Outcome after Unrelated Hematopoietic Stell Cell Transplantation: The Jury Is Still out

Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study

Plerixafor As a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers (NCT01954914)

Long-Term HSC Donor Follow-up: Malignancy Incidences after Donation Are Identical Compared to a Matched Control Sample of Registered Donors, but Different to Expected General Population Rates

Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR

Prediction of Hematopoietic Stem Cell Yield after Mobilization with GCSF in Healthy Unrelated Donors

7/8 High-Resolution Unrelated Donor HLA Match Rate: Caucasian, African American, Hispanic, and Asian-Pacific Islander

Duration of Unrelated Donor Search for Hematopoietic Stem Cell Transplantation

Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association

Follow-up of 12,559 Unrelated Donors of Peripheral Blood Stem Cells or Bone Marrow

Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors

Efficiency of HLA-A, -B, -C, -DRB1 High-Resolution Typings of Newly Recruited Potential Stem Cell Donors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only